Advanced Cancer Care for Cedar Rapids

Receiving a diagnosis of cancer is difficult. St. Luke's is here for you and your family during every step of your journey with services that treat mind, body and spirit. Plus, we're treating cancer earlier than ever before with state-of-the-art cancer risk assessments that find cancer at the earliest stages, when it's easiest to treat.

First North American patient receives experimental drug to treat breast cancer

The first North American patient to be treated with Radium 223 (Xofigo®) or placebo for a metastatic breast cancer diagnosis, has started treatment at Physicians' Clinic of Iowa, as part of an innovative clinical research study. Clinical trials are not new to Cedar Rapids, however, there is a pervasive myth that investigational drugs are only available in large academic settings. This particular trial is available through a partnership among PCI, the Helen G. Nassif Community Cancer Center and UnityPoint Health - St. Luke's Hospital. Each entity has a role in the patient's treatment regimen. Read more.

Albert G. and Helen Nassif Radiation Center

The Albert G. and Helen Nassif Radiation Center completes the full spectrum of cancer care for St. Luke's Hospital and will house the most advanced cancer fighting technology available, external beam radiation therapy.

One out of every two men and one of every three women are expected to be diagnosed with cancer in their lifetimes. According to a 2014 World Health Organization Report cancer cases are expected to surge 57 percent worldwide in the next 20 years and because of this St. Luke's pursued a Certificate of Need (CON) with the State Health Facilities Council earlier this year to bring external beam radiation therapy to St. Luke's.

Establishing the Albert G. and Helen Nassif Radiation Center as a freestanding office-based facility  provides a cost savings to patients who require radiation therapy. The savings per patient is expected to range from 20 to 50 percent. Learn more.

Intraoperative Electron Radiation Therapy (IORT)

Faster, convenient, more precise breast cancer treatment

You've heard the breast cancer diagnosis, and now you're ready for answers. "In one procedure, women can have a cancer operation, radiation to the tumor bed and maintain optimal appearance and symmetry with the other breast. IORT is a concise, convenient and cost-effective treatment. This is true innovation," explains Dr. Robert Brimmer, of Physicians Clinic of Iowa surgeon.

Call (319) 369-7216 to speak with a Breast Care Coordinator. Learn more.

One of the first to offer new prostate cancer treatment

St. Luke's Hospital was among the first hospitals in the state to offer a new radioactive injection for the treatment of advanced prostate cancer. The treatment, called Radium 223 (brand name Xofigo) is a newly approved drug that emits radioactive particles, which can extend the lives of certain men with advanced prostate cancer. It was approved by the Food and Drug Administration (FDA) in May 2013 after a successful clinical trial, and is appropriate for men with prostate cancer whose disease has spread to the bone but not to other organs.  Learn more about this treatment from the American Cancer Society.